Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Understanding Rare Conditions: The Multifaceted Financial Impact

January 26, 2023

More than a third of Health Union’s Myasthenia Gravis In America 2022 survey respondents said their condition has negatively impacted their finances.

Bringing Patient Centricity to Life: Health Union’s Social Health Network

December 7, 2022

Health Union's Social Health Network builds health leaders into confident and trustworthy partners for the healthcare industry. Here's why that matters.

Patient and Caregiver Perspectives: How Pharma Can Improve the Chronic Condition Experience

November 30, 2022

Two health leaders share wins, challenges and opportunities they've faced as patient and caregiver to help pharma improve the chronic condition experience.

Understanding Rare Conditions: Support & Connection

November 8, 2022

The internet has allowed people living with chronic conditions to find information, connection and support that might not have been readily available.

Hepatitis C Patient-Reported Survey Data | 2019

February 25, 2020

New Health Union survey data from hepatitis C patients help the healthcare industry better understand and reach people living with hepatitis C.

Exploring the Cancer Patient Journey on World Cancer Day and Every Day

February 4, 2020

Discover the journey of a cancer patient through patient-reported data and personal interviews outlining diagnosis, treatment, and remission.

Type 2 Diabetes Burnout: What Pharma Can Learn

January 13, 2020

Feelings of diabetes burnout can lead to issues with care management and treatment. Here’s what pharma can learn to help people manage type 2 diabetes.

Seronegative RA and Its Impact on Quality of Life

December 12, 2019

Survey data shows seronegative RA patients are more likely than those with seropositive rheumatoid arthritis to have been misdiagnosed.

Healthcare Industry Thought Leadership

Contact